US equities
|
INTC
$64.75
▼-29.68%
AMZN
$240.33
▼-1.42%
NVDA
$204.43
▼-4.32%
MU
$882.84
▼-5.50%
GOOGL
$280.31
▼-1.24%
SNDK
$1,166.21
▼-12.32%
AMD
$502.81
▼-11.23%
SPCX
$137.89
▼-4.17%
INTC
$64.75
▼-29.68%
AMZN
$240.33
▼-1.42%
NVDA
$204.43
▼-4.32%
MU
$882.84
▼-5.50%
GOOGL
$280.31
▼-1.24%
SNDK
$1,166.21
▼-12.32%
AMD
$502.81
▼-11.23%
SPCX
$137.89
▼-4.17%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Bausch + Lomb
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
October 04, 2023
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
April 13, 2023
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO